User menu

Cost effectiveness of Rivaroxaban versus low molecular weight heparin and vitamin K antagonists for the treatment of deep-vein thrombosis in the Belgian healthcare setting

Bibliographic reference Maervoet, Johan ; Verhamme, Peter ; Hainaut, Philippe ; McLeod, Euan ; Bamber, Luke ; et. al. Cost effectiveness of Rivaroxaban versus low molecular weight heparin and vitamin K antagonists for the treatment of deep-vein thrombosis in the Belgian healthcare setting. In: The European Journal of Cardiovascular Medicine, Vol. 3, no. 1, p. 452-461 (2015)
Permanent URL http://hdl.handle.net/2078.1/172115